Skip to main content

Peer Review reports

From: Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

Original Submission
26 Jul 2012 Submitted Original manuscript
1 Oct 2012 Reviewed Reviewer Report - Yasushi Adachi
16 Nov 2012 Reviewed Reviewer Report - Sven Lang
20 Nov 2012 Reviewed Reviewer Report - Haim Werner
25 Nov 2012 Reviewed Reviewer Report - yoshio naomoto
30 Nov 2012 Reviewed Reviewer Report - Norma O'Donovan
20 Dec 2012 Author responded Author comments - Helmout Modjtahedi
Resubmission - Version 2
20 Dec 2012 Submitted Manuscript version 2
21 Dec 2012 Reviewed Reviewer Report - Haim Werner
28 Dec 2012 Reviewed Reviewer Report - Sven Lang
31 Dec 2012 Reviewed Reviewer Report - Yasushi Adachi
4 Jan 2013 Reviewed Reviewer Report - Norma O'Donovan
6 Jan 2013 Reviewed Reviewer Report - yoshio naomoto
11 Jan 2013 Author responded Author comments - Helmout Modjtahedi
Resubmission - Version 3
11 Jan 2013 Submitted Manuscript version 3
Publishing
28 Jan 2013 Editorially accepted
31 Jan 2013 Article published 10.1186/1471-2407-13-41

You can find further information about peer review here.

Back to article page